Cargando…
Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?
Autores principales: | Szolnoky, Győző, González-Ochoa, Alejandro José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961374/ https://www.ncbi.nlm.nih.gov/pubmed/35333125 http://dx.doi.org/10.1177/10760296221084300 |
Ejemplares similares
-
Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016) -
Sulodexide in IgA nephropathy
Publicado: (2013) -
Lack of Benefit on Treating Asymptomatic Bacteriuria Prior to
Cardiovascular Surgery: a Systematic Review and Meta-Analysis
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2018) -
Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)